Skip to main content
. 2020 Nov 5;21(12):1097–1104. doi: 10.1080/15384047.2020.1834319

Figure 1.

Figure 1.

Clinical and histological data of the patient from our center. (a) The timeline of treatments for a patient with advanced esophageal squamous carcinoma. (b) The PD-L1 expression in tissue sample by IHC using 22C3 (X200)